VITILIGONING ZAMONAVIY DIAGNOSTIK KONSEPSIYALARI: KLINIK BAHOLASH, BIOMARKERLARNI ANIQLASH VA ILG‘OR VIZUALIZATSIYA TEXNOLOGIYALARI
Qabul qilingan: 2026-07-16 04:15:14
Nashr etilgan: 2026-04-18
Annotatsiya
Vitiligo — bu ko‘p omilli depigmentatsion teri kasalligi bo‘lib, melanotsitlarning asta-sekin yo‘qolishi bilan tavsiflanadi va natijada aniq chegaralangan gipоpigmentatsiyalangan yoki depigmentatsiyalangan o‘choqlar paydo bo‘ladi. So‘nggi o‘n yillikda autoimmun mexanizmlar, oksidativ stress yo‘llari va genetik moyillik haqidagi bilimlarning kengayishi diagnostika yondashuvlarini sezilarli darajada o‘zgartirdi. Zamonaviy dermatologiya amaliyoti kasallik faolligini erta aniqlash hamda uni boshqa pigmentatsiya buzilishlaridan farqlashga qaratilgan bo‘lib, bunda noinvaziv vizualizatsiya usullari, laborator biomarkerlar tahlili va raqamli analitik tizimlardan foydalaniladi. Mazkur sharhda vitiligoni aniq baholash uchun zamonaviy diagnostika tamoyillari, klinik belgilar, prognoz omillari va yangi texnologik yechimlar yoritilgan.
Kalit so'zlar
Adabiyotlar ro'yxati
-
Taieb A., Picardo M. (2009). Vitiligo. New England Journal of Medicine, 360(2), 160–169.
-
Ezzedine K., Eleftheriadou V., Whitton M., van Geel N. (2015). Vitiligo. The Lancet, 386(9988),
-
Bergqvist C., Ezzedine K. (2020). Vitiligo: A Review. Dermatology, 236(6), 571–592.
-
Rashighi M., Harris J. (2017). Interferon gamma pathway in vitiligo. Journal of Investigative Dermatology, 137(10), 2077–2084.
-
Rodrigues M., Pandya A. (2017). Advances in Vitiligo Research. Dermatologic Clinics, 35(2), 151–161.
-
Speeckaert R., Dugardin J., Lambert J. (2017). Biomarkers in Vitiligo. Experimental Dermatology, 26(9), 782–790.
-
van Geel N., Mollet I. (2018). Confocal microscopy in pigmentary disorders. Journal of the European Academy of Dermatology and Venereology, 32(9), 1429–1436.
-
Frisoli M., Essien K., Harris J. (2020). Vitiligo: Mechanisms of Pathogenesis. Annual Review of Immunology, 38, 621–648.
-
Dell’Anna M. L., Ottaviani M. (2019). Oxidative stress in vitiligo. Pigment Cell & Melanoma Research, 32(2), 206–215.
-
Hamzavi I., Jain H. (2004). Vitiligo Area Scoring Index (VASI). Journal of the American Academy of Dermatology, 50(5), 824–830.
-
Silverberg J. I. (2015). Association between vitiligo and autoimmune diseases. British Journal of Dermatology, 172(2), 405–412.
-
Whitton M. et al. (2016). Interventions for Vitiligo. Cochrane Database of Systematic Reviews.
-
Krüger C., Schallreuter K. (2012). Pathogenesis of Vitiligo. International Journal of Dermatology, 51(6), 656–667.
-
Passeron T., Ortonne J.P. (2012). Vitiligo and Melanocyte Biology. Pigment Cell & Melanoma Research, 25(6), 667–675.
-
World Health Organization. Skin Diseases and Global Burden Reports. Available at:
-
National Center for Biotechnology Information (NCBI). PubMed Database — Vitiligo Research Articles.
-
American Academy of Dermatology. Vitiligo Clinical Guidelines.
-
European Academy of Dermatology and Venereology Clinical Recommendations for Pigmentary Disorders.
-
National Institutes of Health. Autoimmune Skin Disorders Research Reports.
Mualliflar haqida
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
